NCT05413772View on ClinicalTrials.gov

Temocillin in ESBL-Enterobacteriaceae Infections

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

November 24, 2022

Study Completion Date

November 24, 2022

Conditions
Infectious Disease
Interventions
OTHER

Temocillin

To evaluate the clinical course of patients who received temocillin. To evaluate the efficacy and safety of temocillin in different situations Enterobacteriaceae ESBL infections

Trial Locations (2)

75013

Pitié-Salpêtrière University Hospital, Paris

75020

Tenon University Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER